Tech Company Financing Transactions
Threshold Pharmaceuticals Funding Round
Threshold Pharmaceuticals, operating out of South San Francisco, raised $35 million from Federated Kaufmann Funds, Frazier Healthcare Partners and Great Point Partners.
Transaction Overview
Company Name
Announced On
10/7/2009
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
170 Harbor Way 300
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Threshold is a biotechnology company focused on the discovery and development of small molecule therapeutics based on Metabolic Targeting, a powerful scientific approach that offers broad potential to treat most solid tumors and certain other diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Harold Selick
Chief Medical Officer
Tillman Pearce
VP - Bus. Development
Eric Malek
VP - Finance
Joel Fernandes
VP - Operations
Stewart Kroll
Browse more venture capital transactions:
Prev: 10/7/2009: Engine Yard venture capital transaction
Next: 10/7/2009: Personal Web Solutions venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here come from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs